Considering all of the clinical conditions described herein, muscle mass, adiposity, inflammatory serum markers, tissular mediators, and hormones, like incretins, among others, with endocrine, paracrine, and autocrine effects are relevant in functional muscle mass maintenance in patients with breast cancer and obesity in an insulin-resistant environment [8,9]. The gene discussed is INS; the disease is breast cancer.